[go: up one dir, main page]

YU75093A - Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka - Google Patents

Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka

Info

Publication number
YU75093A
YU75093A YU75093A YU75093A YU75093A YU 75093 A YU75093 A YU 75093A YU 75093 A YU75093 A YU 75093A YU 75093 A YU75093 A YU 75093A YU 75093 A YU75093 A YU 75093A
Authority
YU
Yugoslavia
Prior art keywords
therapy
acetylsalicylic acid
cancer
prophylax
system containing
Prior art date
Application number
YU75093A
Other languages
English (en)
Inventor
F. Becher
Original Assignee
Lts Lohmann Therapie - Sisteme Gmbh. And Co. Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie - Sisteme Gmbh. And Co. Kg. filed Critical Lts Lohmann Therapie - Sisteme Gmbh. And Co. Kg.
Publication of YU75093A publication Critical patent/YU75093A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

TRANSDERMALNI SISTEM ZA DAVANJE KOJI SADRŽI ACETILSALICILNU KISELINU ZA ANTITROMBOZNU TERAPIJU I PROFILAKSU RAKA se odnosi na transdermalni sistem za davanje za antitromboznu terapiju, odnosno za profilaksu protiv raka, koji kao aktivnu materiju sadrži acetilsalicilnu kiselinu i/ili farmaceutski prihvatijive soli iste.
YU75093A 1991-12-20 1993-12-02 Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka YU75093A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4142483 1991-12-20
DE4241128A DE4241128C2 (de) 1991-12-20 1992-12-07 Verwendung eines transdermalen Verabreichungssystems, das als Wirkstoff Acetylsalicylsäure und/oder pharmazeutisch akzeptable Salze davon enthält

Publications (1)

Publication Number Publication Date
YU75093A true YU75093A (sh) 1997-08-22

Family

ID=6447817

Family Applications (1)

Application Number Title Priority Date Filing Date
YU75093A YU75093A (sh) 1991-12-20 1993-12-02 Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka

Country Status (23)

Country Link
US (2) US6264978B1 (sh)
EP (1) EP0617623B1 (sh)
JP (1) JP3748270B2 (sh)
KR (2) KR100267442B1 (sh)
AT (1) ATE217528T1 (sh)
AU (1) AU667067B2 (sh)
CA (1) CA2125662C (sh)
CZ (1) CZ285190B6 (sh)
DE (2) DE4241128C2 (sh)
DK (1) DK0617623T3 (sh)
ES (1) ES2176197T3 (sh)
FI (1) FI113838B (sh)
HR (1) HRP921157A2 (sh)
HU (1) HU221679B1 (sh)
IL (1) IL103917A (sh)
NO (1) NO306599B1 (sh)
NZ (1) NZ246158A (sh)
PT (1) PT617623E (sh)
SI (1) SI9200312A (sh)
SK (1) SK67094A3 (sh)
WO (1) WO1993012799A1 (sh)
YU (1) YU75093A (sh)
ZA (1) ZA922814B (sh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
CA2150033A1 (en) * 1992-12-07 1994-06-23 Frank Becher Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
AU6709096A (en) * 1995-07-27 1997-02-26 Cal International Limited Pharmaceutical preparation for percutaneous absorbtion
WO1997004757A1 (en) * 1995-07-27 1997-02-13 Cal International Limited Transdermal nitrate formulation
AU6709196A (en) * 1995-07-27 1997-02-26 Cal International Limited Transdermal patch containing aspirin
DE69635298T2 (de) * 1995-12-26 2006-07-13 Teikoku Seiyaku K.K. Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen
DE19601487C2 (de) * 1996-01-17 2001-09-13 Micronas Gmbh Vorrichtung zum Behandeln von malignen Gewebsveränderungen
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
RU2201234C2 (ru) * 2000-12-05 2003-03-27 Воронежский государственный университет Полимерный водорастворимый аналог ацетилсалициловой кислоты и способ его получения
WO2003018023A1 (en) * 2001-08-23 2003-03-06 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
WO2008007171A1 (en) 2006-07-09 2008-01-17 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
AU2008251478B2 (en) * 2007-05-09 2012-01-12 Buckman Laboratories International, Inc. ASA sizing emulsions for paper and paperboard
CA2691446C (en) * 2007-06-04 2021-07-06 Techfields Inc Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
KR20200022525A (ko) 2008-12-04 2020-03-03 충시 위 고투과력을 가진 조성물 및 이의 적용
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
KR102332837B1 (ko) 2012-01-18 2021-12-01 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
FR2297612A1 (fr) 1975-01-20 1976-08-13 Moorleghem Guy Van Procede de fabrication d'un produit analgesique a usage externe
US4012508A (en) 1975-02-03 1977-03-15 Burton Verna M Topical composition and method
US4219548A (en) 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
FR2496459A1 (fr) 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
IL68965A (en) 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4640689A (en) 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
DE3583698D1 (de) 1984-04-23 1991-09-12 Kao Corp Perkutaner absorptions-beschleuniger und diesen enthaltendes praeparat.
JPS61167615A (ja) 1985-01-18 1986-07-29 Teisan Seiyaku Kk 薬剤投与方法
US4810699A (en) 1987-02-20 1989-03-07 American Home Products Corporation Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
JPH01203336A (ja) 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
JPH01242521A (ja) 1988-03-23 1989-09-27 Nikko Kemikaruzu Kk 経皮吸収性を高めた消炎鎮痛薬組成物
US4975269A (en) 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
WO1992020343A1 (en) * 1991-04-03 1992-11-26 Gunderson Medical Foundation, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin

Also Published As

Publication number Publication date
JP3748270B2 (ja) 2006-02-22
JPH07502521A (ja) 1995-03-16
EP0617623B1 (de) 2002-05-15
DK0617623T3 (da) 2002-09-09
EP0617623A1 (de) 1994-10-05
CA2125662A1 (en) 1993-07-08
AU667067B2 (en) 1996-03-07
NO942325L (no) 1994-06-17
SK67094A3 (en) 1995-03-08
NO306599B1 (no) 1999-11-29
DE4241128A1 (en) 1993-06-24
IL103917A (en) 1996-09-12
ATE217528T1 (de) 2002-06-15
FI942922L (fi) 1994-06-17
NO942325D0 (no) 1994-06-17
US5861170A (en) 1999-01-19
PT617623E (pt) 2002-10-31
DE4241128C2 (de) 1996-05-23
FI942922A0 (fi) 1994-06-17
SI9200312A (en) 1993-06-30
CZ145694A3 (en) 1995-01-18
ES2176197T3 (es) 2002-12-01
AU3158993A (en) 1993-07-28
KR100267359B1 (ko) 2000-11-01
HRP921157A2 (en) 1994-10-31
DE59209956D1 (de) 2002-06-20
ZA922814B (en) 1993-06-23
KR100267442B1 (ko) 2000-11-01
CZ285190B6 (cs) 1999-06-16
HU9401849D0 (en) 1994-09-28
WO1993012799A1 (de) 1993-07-08
IL103917A0 (en) 1993-04-04
FI113838B (fi) 2004-06-30
CA2125662C (en) 2006-10-17
HU221679B1 (hu) 2002-12-28
HUT74559A (en) 1997-01-28
NZ246158A (en) 1995-10-26
US6264978B1 (en) 2001-07-24
KR950703972A (ko) 1995-11-17

Similar Documents

Publication Publication Date Title
YU75093A (sh) Transdermalni sistem za davanje koji sadrži acetilsalicilnu kiselinu za antitromboznu terapiju i profilaksu raka
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
BG60261B1 (bg) Лекарствена форма на цефаклор с продължително действие
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
PT814796E (pt) Uso de um farmaco r-aine numa composicao protectora para o tratamento do cancro colorectal
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
EP0209689A3 (en) Use of tetrahydrobiopterins in the treatment of infantile autism
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
DE69209323D1 (de) Mehrschichttabletten mit gesteuerter wirkstoffabgabe enthaltend sowohl naproxen als auch naproxen natriumsalz
FI920324A7 (fi) Valmiste sellaisten vaikuttavien aineiden kontrolloituun vapautumiseen, jotka sopivat terapeuttisiksi aineiksi tai parantamaan kasvua ja ruoan hyväksikäyttöä märehtijöillä
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
EP0137542A3 (en) Pharmaceutical composition for the treatment of states of acute renal insufficiency
ES2126114T3 (es) Composiciones liquidas estables de interferon gamma.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
DK0714304T3 (da) Terapeutisk system til behandling af psoriasis
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ATE65912T1 (de) Arzneimittelzusammensetzungen ermaessigter toxizitaet.
WO1987000432A3 (en) Use of melatonin or related compounds for the treatment of psoriasis
PT651654E (pt) Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa
ES2129563T3 (es) Empleo de una combinacion de un inhibidor de la enzima convertidora de angiotensina y un antagonista del calcio para el tratamiento de una proteinuria.
YU107692A (sh) Sulfonamidi i postupak za njihovo dobijanje